Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Pratap Neelakantan, David Marin, Mike Laffan, John Goldman, Jane Apperley, Dragana Milojkovic

Research output: Contribution to journalLetterpeer-review

30 Scopus citations
Original languageEnglish (US)
Pages (from-to)1444
Number of pages1
JournalHaematologica
Volume97
Issue number9
DOIs
StatePublished - 2012

Keywords

  • BCR-ABL
  • Chronic myeloid leukemia
  • Panatinib
  • Platelet function
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Hematology

Cite this